Rep. Nagel says information program for non‑opioid pain care aims to improve outcomes; insurance official says fiscal impact indeterminate
Loading...
Summary
Representative Dave Nagel told the committee his bill would steer patients to covered non‑opioid therapies and reduce long‑term opioid use. Michelle Heaton of the Insurance Department said the panelized plan focuses on access and prior‑authorization changes; the fiscal note was characterized as indeterminable.
Representative Dave Nagel, the bill's sponsor and a clinician, framed House Bill 241 as a long‑running, bipartisan effort to broaden access to non‑opioid pain‑management options and to provide a roadmap for patients and providers.
"The question was never the concept, but how?" Nagel said, describing work with stakeholders and citing evidence from a VA pilot he said showed a 38% reduction in opioid use and fewer spine procedures. He described the bill as a starting point—an information and program approach rather than a coverage mandate.
Michelle Heaton, director of life and health at the New Hampshire Insurance Department, told the committee the department assisted in drafting an amended bill intended to limit fiscal exposure. Under the Affordable Care Act benchmark plan rules, Heaton said, adding benefits can trigger a state obligation to defray costs for the benchmark population, so the bill was rewritten to focus on compiling existing covered services into a program and reducing prior‑authorization barriers for non‑opioid treatments. "There could be cost savings," she said, but the department's fiscal note treated the long‑term impact as indeterminable because outcomes vary by patient.
Committee members asked whether the measure would require insurers to cover treatments such as acupuncture. Heaton said the carriers would only list and promote covered options; if a benefit is not in the benchmark plan, adding it could create an obligation to defray costs for benchmark plan enrollees. Nagel and Heaton said the bill aims to steer care toward conservative, evidence‑based options where appropriate, not to mandate new benefits.
The committee did not take a vote. Members requested copies of the treasurer's debt‑capacity report and further fiscal analysis on insurance implications as the session continues.
